More specifically, the developed nanoMIPstargeted a linear epitope of estrogen receptor alpha (ERα),and the nanoMIPs were loaded with drug doxorubicin to achieve specificdrug delivery toward ERα+ positive breast cancer cells (Figure 3).76 Here, ESR1 is linked to breast carcinoma.